Diabetes Archives - Market Exclusive

Home Tags Diabetes

For Diabetes Patients, Management Solutions Are As Critical As Medications

ME Staff - May 10, 2018

With $12.2M in CIRM Funding, Caladrius Biosciences Inc. (NASDAQ:CLBS) Takes On...

David Rich - February 24, 2017

Caladrius Biosciences Inc (NASDAQ:CLBS) Way Oversold As 2016 Comes to a...

ME Contributor - January 3, 2017

Delving Into The Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Data

ME Contributor - September 12, 2016

Inside The FDA: Eli Lilly and Co (NYSE:LLY) Jardiance Aims at...

David Rich - September 9, 2016

Here’s What Opko Gets For Its $60 Million Transition Fee –...

ME Contributor - July 5, 2016

As Old Bestsellers Plateau, a Look at 4 Next Generation Diabetes...

David Rich - June 27, 2016

Innocoll Holdings PLC (NASDAQ:INNL) Could Pick Up Two US Approvals Before...

ME Contributor - June 27, 2016

The Top Four Diabetes Best Sellers and One Oral Insulin Pill...

David Rich - June 22, 2016

How Does MannKind Corporation (NASDAQ:MNKD)’s Afrezza Compare With Mealtime Insulin?

ME Contributor - June 13, 2016

12 Page 1 of 2

/* */

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 12, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

October 29, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

October 15, 2023

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: Diabetes

For Diabetes Patients, Management Solutions Are As Critical As Medications

With $12.2M in CIRM Funding, Caladrius Biosciences Inc. (NASDAQ:CLBS) Takes On...

Caladrius Biosciences Inc (NASDAQ:CLBS) Way Oversold As 2016 Comes to a...

Delving Into The Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Data

Inside The FDA: Eli Lilly and Co (NYSE:LLY) Jardiance Aims at...

Here’s What Opko Gets For Its $60 Million Transition Fee –...

As Old Bestsellers Plateau, a Look at 4 Next Generation Diabetes...

Innocoll Holdings PLC (NASDAQ:INNL) Could Pick Up Two US Approvals Before...

The Top Four Diabetes Best Sellers and One Oral Insulin Pill...

How Does MannKind Corporation (NASDAQ:MNKD)’s Afrezza Compare With Mealtime Insulin?

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY